ConductScience.org, home

Paper7012015

Factors influencing release of type III antigens by group B streptococci.

Doran TI and 2 others. Infect Immun, 1981. Cited by 26 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Factors influencing release of type III antigens by group B streptococci. Papers, record 7012015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7012015

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors influencing release of type III antigens by group B streptococci.
PubMed
Journal
Infect Immun
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Doran TIT I
2Straus DCD C
3Mattingly SJS J

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Polysaccharides, BacterialMajor topic
Streptococcus agalactiaeMajor topic
Bacterial Proteins
Culture Media
Glucose
Phosphates

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
13836PHS HHSUnited StatesPubMed

Source PubMed

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1344,339Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.J Clin Microbiol1978https://conductscience.org/library/papers/344339PubMed
255,386Identification of sialic acid in polysaccharide antigens in group B Streptococcus.Infect Immun1976https://conductscience.org/library/papers/55386PubMed
3804,441Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic.Infect Immun1975https://conductscience.org/library/papers/804441PubMed
45,220,562Type-specific polysaccharide antigens of group B streptococci.J Hyg (Lond)1966https://conductscience.org/library/papers/5220562PubMed
55,005,310Type-specific antigens of group B type Ic streptococci.Infect Immun1971https://conductscience.org/library/papers/5005310PubMed
66,154,921Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease.Pediatrics1980https://conductscience.org/library/papers/6154921PubMed
76,155,346Soluble group- and type-specific antigens from type III group B Streptococcus.Infect Immun1980https://conductscience.org/library/papers/6155346PubMed
833,225Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.J Exp Med1979https://conductscience.org/library/papers/33225PubMed
9342,537Growth and amino acid requirements of various strains of group B streptococci.J Clin Microbiol1978https://conductscience.org/library/papers/342537PubMed
10376,808Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination.J Pediatr1979https://conductscience.org/library/papers/376808PubMed
112,557Microcapsule of type III strains of group B Streptococcus: production and morphology.Infect Immun1976https://conductscience.org/library/papers/2557PubMed
1221,168Secretion of lipids induced by inhibition of peptidoglycan synthesis in streptococci.J Bacteriol1977https://conductscience.org/library/papers/21168PubMed
1316,558,119Significance of circulating capsular antigen in Klebsiella infections.Infect Immun1976https://conductscience.org/library/papers/16558119PubMed
144,433,537Penicillin-induced secretion of soluble, uncross-linked peptidoglycan by Micrococcus luteus cells.Biochemistry1974https://conductscience.org/library/papers/4433537PubMed
154,608,888Group B streptococcal infections in infants. The importance of the various serotypes.JAMA1974https://conductscience.org/library/papers/4608888PubMed
167,012,176Protease production by clinical isolates of type III group B streptococci.J Clin Microbiol1980https://conductscience.org/library/papers/7012176PubMed
17892,902Factors regulating cell wall thickening and intracellular iodophilic polysaccharide storage in Streptococcus mutans.Infect Immun1977https://conductscience.org/library/papers/892902PubMed
186,155,983Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus.Can J Biochem1980https://conductscience.org/library/papers/6155983PubMed
19361,576Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.Infect Immun1978https://conductscience.org/library/papers/361576PubMed
2068,081Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.J Immunol1977https://conductscience.org/library/papers/68081PubMed

See all 28 references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
18,806,000Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains.Appl Environ Microbiol2008https://conductscience.org/library/papers/18806000PubMed
17,171,465High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.Curr Microbiol2007https://conductscience.org/library/papers/17171465PubMed
9,350,760Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.J Clin Microbiol1997https://conductscience.org/library/papers/9350760PubMed
8,606,082Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.Infect Immun1996https://conductscience.org/library/papers/8606082PubMed
8,478,074Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.Infect Immun1993https://conductscience.org/library/papers/8478074PubMed
7,047,392Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.Infect Immun1982https://conductscience.org/library/papers/7047392PubMed
7,030,959Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.Infect Immun1981https://conductscience.org/library/papers/7030959PubMed
6,423,540Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.Infect Immun1984https://conductscience.org/library/papers/6423540PubMed
6,370,860Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.Infect Immun1984https://conductscience.org/library/papers/6370860PubMed
6,363,297Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.Infect Immun1984https://conductscience.org/library/papers/6363297PubMed
6,363,289Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.Infect Immun1984https://conductscience.org/library/papers/6363289PubMed
6,352,490Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.Infect Immun1983https://conductscience.org/library/papers/6352490PubMed
6,341,233Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.Infect Immun1983https://conductscience.org/library/papers/6341233PubMed
6,339,471Biosynthesis of cell wall peptidoglycan and polysaccharide antigens by protoplasts of type III group B Streptococcus.J Bacteriol1983https://conductscience.org/library/papers/6339471PubMed
6,192,084Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.Infect Immun1983https://conductscience.org/library/papers/6192084PubMed
3,134,236Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/3134236PubMed
2,995,256Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci.Infect Immun1985https://conductscience.org/library/papers/2995256PubMed
2,660,146Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2660146PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NEU14,758PubTator's text mininghttps://conductscience.org/library/genes/4758

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7012015

GET https://conductscience.org/api/papers/v1/7012015/references?page=2